Panagiotis Bouris Selected Research

serglycin

5/2020	Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
12/2018	Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
1/2015	Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Panagiotis Bouris Research Topics

Disease

6	Neoplasms (Cancer) 05/2020 - 08/2014
5	Breast Neoplasms (Breast Cancer) 12/2018 - 04/2015
2	Colonic Neoplasms (Colon Cancer) 01/2015 - 08/2014
1	Brain Neoplasms (Brain Tumor) 05/2020
1	Glioblastoma (Glioblastoma Multiforme) 05/2020
1	Disease Progression 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Inflammation (Inflammations) 11/2014

Drug/Important Bio-Agent (IBA)

3	serglycinIBA 05/2020 - 01/2015
3	Proteoglycans (Proteoglycan)IBA 12/2018 - 11/2014
2	Estrogen ReceptorsIBA 12/2018 - 12/2016
2	Hormones (Hormone)IBA 12/2016 - 04/2015
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Interleukin-8 (Interleukin 8)IBA 12/2018
1	ChemokinesIBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 12/2017
1	Small Interfering RNA (siRNA)IBA 12/2016
1	Estrogen Receptor betaIBA 12/2016
1	Pharmaceutical PreparationsIBA 12/2016
1	CollagenIBA 12/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016
1	Protein Isoforms (Isoforms)IBA 12/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2016
1	Estrogen Receptor alphaIBA 04/2015
1	Peptide Hydrolases (Proteases)FDA Link 11/2014
1	Biological ProductsIBA 11/2014
1	Epidermal Growth Factor (EGF)IBA 08/2014
1	ErbB Receptors (EGF Receptor)IBA 08/2014